Saudi Arabia: Suspension and fine for endurance rider over horse’s failed drug test

Horsetalk.co.nz - Full Article

July 25, 2017
Horsetalk.co.nz

A rider in Saudi Arabia has been suspended for a year and fined 2500 Swiss francs after his mount in a 110km endurance ride last January tested positive for phenylbutazone, oxyphenbutazone, and dexamethasone.

Ibrahim Abdulrahman Alsughayer rode the horse Nashmi Alghzlan in a CEI1* 110km race in Riyadh, Saudi Arabia, on January 14.

The horse was selected for testing, which revealed the presence of the three substances in the blood. Phenylbutazone and dyphenbutazone – a metabolic byproduct of phenylbutazone – are non-steroidal anti-inflammatory drugs with anti-inflammatory and painkilling effects. Dexamethasone is a corticosteroid drug with anti-inflammatory properties...

Read more at http://www.horsetalk.co.nz/2017/07/25/suspension-fine-endurance-horse-drug/#uO7Pb2PBHLwi5Lpd.99